| Source HCPCS Code |
|
Target NDC Code |
J7677
Revefenacin inj non-com 1mcg
|
⇄
|
49502-0806-32
YUPELRI 175 MCG/3 ML SOLUTI
|
| Detail Information |
| Relationship Start Date |
07/01/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
J7677
REVEFENACIN INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, 1 MICROGRAM
|
⇄
|
49502-0806-77
YUPELRI (SAMPLE) 175 MCG/3 ML
|
| Detail Information |
| Relationship Start Date |
12/14/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
J7677
REVEFENACIN INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, 1 MICROGRAM
|
⇄
|
49502-0806-93
YUPELRI 175 mcg/3 ml
|
| Detail Information |
| Relationship Start Date |
07/01/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
J7677
Revefenacin inh non-com 1mcg
|
⇄
|
49502-0806-93
Yupelri
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|